APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cortisone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cortisone Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchCortisone Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cortisone Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Cortisone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cortisone Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cortisone Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Cortisone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cortisone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cortisone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cortisone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cortisone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cortisone market include Novartis, Merck, Pfizer, GlaxoSmithKline, AstraZeneca and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cortisone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cortisone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cortisone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cortisone market size, projected growth trends, production technologies, key applications, and end-use industries.

Cortisone Segment by Company

Novartis

Merck

Pfizer

GlaxoSmithKline

AstraZeneca

Bristol-Myers Squibb

Cortisone Segment by Type

Oral Drugs

Injectable Drugs

Cortisone Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Cortisone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cortisone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cortisone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cortisone significant trends, drivers, influence factors in global and regions.

6. To analyze Cortisone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cortisone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cortisone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cortisone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cortisone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cortisone industry.

Chapter 3: Detailed analysis of Cortisone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cortisone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cortisone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cortisone Industry Trends Table 2. Cortisone Industry Drivers Table 3. Cortisone Industry Opportunities and Challenges Table 4. Cortisone Industry Restraints Table 5. Global Cortisone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cortisone Revenue Share by Company (2021-2026) Table 7. Global Cortisone Sales Volume by Company (k units) & (2021-2026) Table 8. Global Cortisone Sales Volume Share by Company (2021-2026) Table 9. Global Cortisone Average Price (US$/unit) of Company (2021-2026) Table 10. Global Cortisone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cortisone Key Company Manufacturing Base & Headquarters Table 12. Global Cortisone Company, Product Type & Application Table 13. Global Cortisone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cortisone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Drugs Table 18. Significant Companies of Injectable Drugs Table 19. Global Cortisone Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Cortisone Sales Volume by Type (2021-2026) & (k units) Table 21. Global Cortisone Sales Volume by Type (2027-2032) & (k units) Table 22. Global Cortisone Sales Volume Share by Type (2021-2026) Table 23. Global Cortisone Sales Volume Share by Type (2027-2032) Table 24. Global Cortisone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cortisone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cortisone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cortisone Sales Value Share by Type (2021-2026) Table 28. Global Cortisone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacies Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Global Cortisone Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Cortisone Sales Volume by Application (2021-2026) & (k units) Table 34. Global Cortisone Sales Volume by Application (2027-2032) & (k units) Table 35. Global Cortisone Sales Volume Share by Application (2021-2026) Table 36. Global Cortisone Sales Volume Share by Application (2027-2032) Table 37. Global Cortisone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cortisone Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Cortisone Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Cortisone Sales Value Share by Application (2021-2026) Table 41. Global Cortisone Sales Value Share by Application (2027-2032) Table 42. Global Cortisone Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Cortisone Sales by Region (2021-2026) & (k units) Table 44. Global Cortisone Sales Market Share by Region (2021-2026) Table 45. Global Cortisone Sales by Region (2027-2032) & (k units) Table 46. Global Cortisone Sales Market Share by Region (2027-2032) Table 47. Global Cortisone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Cortisone Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Cortisone Sales Value Share by Region (2021-2026) Table 50. Global Cortisone Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Cortisone Sales Value Share by Region (2027-2032) Table 52. Global Cortisone Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Cortisone Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Cortisone Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Cortisone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Cortisone Sales by Country (2021-2026) & (k units) Table 57. Global Cortisone Sales Market Share by Country (2021-2026) Table 58. Global Cortisone Sales by Country (2027-2032) & (k units) Table 59. Global Cortisone Sales Market Share by Country (2027-2032) Table 60. Global Cortisone Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Cortisone Sales Value Market Share by Country (2021-2026) Table 62. Global Cortisone Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Cortisone Sales Value Market Share by Country (2027-2032) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Cortisone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Novartis Cortisone Product Portfolio Table 68. Novartis Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Cortisone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Merck Cortisone Product Portfolio Table 73. Merck Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Cortisone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Pfizer Cortisone Product Portfolio Table 78. Pfizer Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Cortisone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Cortisone Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. AstraZeneca Company Information Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Cortisone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. AstraZeneca Cortisone Product Portfolio Table 88. AstraZeneca Recent Development Table 89. Bristol-Myers Squibb Company Information Table 90. Bristol-Myers Squibb Business Overview Table 91. Bristol-Myers Squibb Cortisone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Bristol-Myers Squibb Cortisone Product Portfolio Table 93. Bristol-Myers Squibb Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Cortisone Distributors List Table 97. Cortisone Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Cortisone Product Image Figure 2. Global Cortisone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cortisone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cortisone Sales (2021-2032) & (k units) Figure 5. Global Cortisone Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Cortisone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Drugs Image Figure 10. Injectable Drugs Image Figure 11. Global Cortisone Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Cortisone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cortisone Sales Volume Share by Type (2021-2032) Figure 14. Global Cortisone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cortisone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cortisone Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Retail Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Global Cortisone Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Cortisone Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Cortisone Sales Volume Share by Application (2021-2032) Figure 23. Global Cortisone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cortisone Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Cortisone Sales Value Share by Application (2021-2032) Figure 26. Global Cortisone Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Cortisone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Cortisone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Cortisone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Cortisone Sales Value (2021-2032) & (US$ Million) Figure 31. North America Cortisone Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Cortisone Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Cortisone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Cortisone Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Cortisone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Cortisone Sales Value (2021-2032) & (US$ Million) Figure 37. South America Cortisone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Cortisone Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Cortisone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Cortisone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Cortisone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Cortisone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Cortisone Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Cortisone Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Drugs
  • Injectable Drugs
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cortisone Sales Value (2021-2032)
  4. 1.2.2 Global Cortisone Sales Volume (2021-2032)
  5. 1.2.3 Global Cortisone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cortisone Market Dynamics
  1. 2.1 Cortisone Industry Trends
  2. 2.2 Cortisone Industry Drivers
  3. 2.3 Cortisone Industry Opportunities and Challenges
  4. 2.4 Cortisone Industry Restraints
3 Cortisone Market by Company
  1. 3.1 Global Cortisone Company Revenue Ranking in 2025
  2. 3.2 Global Cortisone Revenue by Company (2021-2026)
  3. 3.3 Global Cortisone Sales Volume by Company (2021-2026)
  4. 3.4 Global Cortisone Average Price by Company (2021-2026)
  5. 3.5 Global Cortisone Company Ranking (2024-2026)
  6. 3.6 Global Cortisone Company Manufacturing Base and Headquarters
  7. 3.7 Global Cortisone Company Product Type and Application
  8. 3.8 Global Cortisone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cortisone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cortisone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cortisone Market by Type
  1. 4.1 Cortisone Type Introduction
  2. 4.1.1 Oral Drugs
  3. 4.1.2 Injectable Drugs
  4. 4.2 Global Cortisone Sales Volume by Type
  5. 4.2.1 Global Cortisone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cortisone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cortisone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cortisone Sales Value by Type
  9. 4.3.1 Global Cortisone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cortisone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cortisone Sales Value Share by Type (2021-2032)
5 Cortisone Market by Application
  1. 5.1 Cortisone Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Cortisone Sales Volume by Application
  6. 5.2.1 Global Cortisone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cortisone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Cortisone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Cortisone Sales Value by Application
  10. 5.3.1 Global Cortisone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cortisone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Cortisone Sales Value Share by Application (2021-2032)
6 Cortisone Regional Sales and Value Analysis
  1. 6.1 Global Cortisone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cortisone Sales by Region (2021-2032)
  3. 6.2.1 Global Cortisone Sales by Region: 2021-2026
  4. 6.2.2 Global Cortisone Sales by Region (2027-2032)
  5. 6.3 Global Cortisone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cortisone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cortisone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cortisone Sales Value by Region (2027-2032)
  9. 6.5 Global Cortisone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cortisone Sales Value (2021-2032)
  12. 6.6.2 North America Cortisone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cortisone Sales Value (2021-2032)
  15. 6.7.2 Europe Cortisone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cortisone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cortisone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cortisone Sales Value (2021-2032)
  21. 6.9.2 South America Cortisone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cortisone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cortisone Sales Value Share by Country, 2025 VS 2032
7 Cortisone Country-level Sales and Value Analysis
  1. 7.1 Global Cortisone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cortisone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cortisone Sales by Country (2021-2032)
  4. 7.3.1 Global Cortisone Sales by Country (2021-2026)
  5. 7.3.2 Global Cortisone Sales by Country (2027-2032)
  6. 7.4 Global Cortisone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cortisone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cortisone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cortisone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cortisone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cortisone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cortisone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cortisone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cortisone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cortisone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cortisone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cortisone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cortisone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cortisone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cortisone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cortisone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cortisone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cortisone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cortisone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cortisone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cortisone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cortisone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cortisone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cortisone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cortisone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cortisone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cortisone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cortisone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cortisone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cortisone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cortisone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cortisone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cortisone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cortisone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cortisone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cortisone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cortisone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cortisone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cortisone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cortisone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cortisone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cortisone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cortisone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cortisone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cortisone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cortisone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cortisone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cortisone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cortisone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cortisone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cortisone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cortisone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cortisone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cortisone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cortisone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cortisone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cortisone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cortisone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cortisone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cortisone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cortisone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cortisone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cortisone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cortisone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cortisone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cortisone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cortisone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cortisone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cortisone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cortisone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cortisone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cortisone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cortisone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cortisone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cortisone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cortisone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cortisone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cortisone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cortisone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cortisone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cortisone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cortisone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cortisone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cortisone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cortisone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cortisone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cortisone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Cortisone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Cortisone Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Cortisone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Cortisone Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Cortisone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Cortisone Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Cortisone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Cortisone Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Cortisone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Cortisone Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Bristol-Myers Squibb
  32. 8.6.1 Bristol-Myers Squibb Company Information
  33. 8.6.2 Bristol-Myers Squibb Business Overview
  34. 8.6.3 Bristol-Myers Squibb Cortisone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bristol-Myers Squibb Cortisone Product Portfolio
  36. 8.6.5 Bristol-Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cortisone Value Chain Analysis
  2. 9.1.1 Cortisone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cortisone Sales Mode & Process
  6. 9.2 Cortisone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cortisone Distributors
  9. 9.2.3 Cortisone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst